Intervention

amlodipine/valsartan

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

Study of Efficacy and Safety of CVAA489 in Hypertensive PatientsNCT02062645 · 2014-02-01

COMPLETED

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic SyndromeNCT01819220 · 2009-04-01

COMPLETED

Common conditions

Essential Hypertension1 Hypertension1

Leading sponsors

Novartis Pharmaceuticals 1 Yonsei University 1

Trial status mix

COMPLETED2

Phase mix

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.